Form 4: Universal Health Services CEO Marc D. Miller Reports Stock Grant

Marc D. Miller, President and CEO of Universal Health Services, reports the acquisition of restricted stock units.

Summary

• On March 21, 2024, Marc D. Miller, President and CEO of Universal Health Services Inc., reported a transaction involving Class B Common Stock.
• Miller acquired 22,755 shares of Class B Common Stock at $0.
• These restricted stock units were granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan.
• The units will vest ratably on March 21 of 2025, 2026, 2027, and 2028.
• Following the reported transaction, Miller directly owns 205,273 shares of Class B Common Stock.
• Miller also indirectly owns shares through various trusts and LLCs.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders. The vesting schedule indicates a long-term commitment.

Positives

• The grant of restricted stock units aligns the CEO's interests with those of the shareholders, incentivizing long-term performance.
• The vesting schedule encourages continued service and commitment from the CEO over the next four years.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock units suggests an expectation of continued service and performance from the CEO.

Industry Context

Insider transactions are common in publicly traded companies and are closely monitored by regulators and investors. Grants of restricted stock are a typical form of executive compensation in the healthcare industry.

Comparison to Industry Standards

• Stock grants are a common component of executive compensation packages in the healthcare industry, aligning executive incentives with shareholder value.
• Companies like HCA Healthcare and Tenet Healthcare also utilize stock grants as part of their executive compensation plans.
• The vesting schedule of these grants is generally consistent with industry norms, typically ranging from three to five years.

Stakeholder Impact

• Shareholders may view the stock grant positively as it incentivizes the CEO to drive long-term value.
• Employees may see the grant as a sign of the company's commitment to its leadership.
• The grant has no immediate impact on customers, suppliers, or creditors.

Key Dates